AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 73,224 Value ($000) $885 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 68,877 Value ($000) $936 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 151,502 Value ($000) $971 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 270,006 Value ($000) $956 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 306,744 Value ($000) $1,159 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 691,066 Value ($000) $2,239 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 1,308,181 Value ($000) $2,486 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 1,042,583 Value ($000) $2,961 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 546,965 Value ($000) $8,051 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 760,290 Value ($000) $13,921 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 1,590,044 Value ($000) $34,297 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 2,022,370 Value ($000) $59,336 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 1,383,732 Value ($000) $51,129 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 162,265 Value ($000) $4,568 Avg Close $24.95 Range $15.80 - $32.80